Galien week of innovation


OCT. 23-27

Galien Medal
BIOTECH - Wednesday Oct. 25


2 PM - 3 PM ET I Cancer

What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?

Kailash Headshot

Kailash Swarna
Managing Director & Global Lead of Clinical Development for Life Sciences R&D, Accenture

Lu Song_BeiGene

Lusong Luo
Senior VP, External Innovation, BeiGene


Gerold - ENHERTU - GWI spokesperson

Gerold Meinhardt
Vice President, Global Lead Oncology Development, Daiichi Sankyo & AstraZeneca

Michael Vasconcelles - ImmunoGen

Michael Vasconcelles, MD, PhD
Executive VP, Research, Development, and Medical Affairs, ImmunoGen, Inc.

Jazz Pharmaceuticals - Rylaze


Rachel Kobos

Dr. Rachel Kobos, MD
Vice President Oncology Research & Development, The Janssen Pharmaceutical Companies of Johnson & Johnson

Jordan Schecter-1

Dr. Jordan Schecter, MD
Vice President for Cellular Therapy, The Janssen Pharmaceutical Companies of Johnson & Johnson

Megan - ADCETRIS - GWI spokesperson

Megan O’Meara
Senior Vice President, Head of Clinical Development, Seagen Inc. 

3 PM - 4 PM ET I Vaccines

In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases?


Nafeez Zawahir, MD
CMO, Razorfish Health


Merck & Co., Inc. - VAXNEUVANCE


Alejandra Gurtman_pfizer

Alejandra Gurtman
Senior Vice President, Vaccine Clinical Research & Development, Vaccines, Pfizer Inc. 

VBI Vaccines, Inc. - PreHevbrio


4 PM- 5 PM ET I Genetic, Autoimmune and Chronic Disorders

As more complex conditions respond to improvements in our understanding of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?

Amir Kalali-1

Amir Kalali
Chairman & Chief Curator CNS Summit/Co-Chair Decentralized Trial Research Alliance


Albireo Pharma, Inc. - Bylvay


argenx - VYVGART

Amy Sehnert - Bristol Myers Squibb

Amy Sehnert
Vice President, Head of Cardiomyopathy and Heart Failure Clinical Development, Bristol Myers Squibb

Regeneron Pharmaceuticals, Inc. - Evkeeza®

Regeneron Pharmaceuticals, Inc. and Sanofi - Dupixent® (dupilumab);

XVIVO Perfusion